Violation Tracker Parent Company Summary

Parent Company Name: 
Amgen
Ownership Structure: 
publicly traded (ticker symbol AMGN)
Headquartered in: 
California
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$912,614,069
Number of records: 
20
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$833,000,0003
government-contracting-related offenses$76,464,0009
employment-related offenses$3,073,7013
environment-related offenses$70,9684
safety-related offenses$5,4001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$833,000,0003
False Claims Act and related$76,464,0009
benefit plan administrator violation$2,750,0001
employment discrimination$283,7011
environmental violation$70,9684
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Primary Offense Type Year Agency Penalty Amountsort icon
Amgen Inc. off-label or unapproved promotion of medical products 2012 FDA $762,000,000
Amgen Inc. off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $612,000,000
Amgen Inc. off-label or unapproved promotion of medical products 2015 MULTI-AG $71,000,000
Amgen Inc. False Claims Act and related 2013 DOJ_CIVIL $24,900,000
Amgen Inc. False Claims Act and related 2019 DOJ_CIVIL $24,750,000
Amgen, Inc. False Claims Act and related 2013 MULTI-AG $11,000,000
Amgen Inc. False Claims Act and related 2009 IL-AG $7,200,000
Amgen and Immunex False Claims Act and related 2008 AL-AG $3,500,000
Amgen, Inc. benefit plan administrator violation 2017 private lawsuit-federal $2,750,000
Amgen, Inc. False Claims Act and related 2009 KY-AG $2,400,000
Amgen Inc. False Claims Act and related 2008 WI-AG $2,000,000
Amgen, Inc. False Claims Act and related 2009 IA-AG $357,000
Immunex Corp. False Claims Act and related 2009 IA-AG $357,000
Amgen, Inc. employment discrimination 2018 OFCCP $283,701
Amgen, Inc. labor relations violation 2011 NLRB $40,000
Amgen Inc. environmental violation 2007 EPA $24,368
Amgen Manufacturing, Limited environmental violation 2006 EPA $20,000
AMGEN INC environmental violation 2002 MA-ENV $15,000
AMGEN INC environmental violation 2006 MA-ENV $11,600
AMGEN SF, LLC workplace safety or health violation 2013 OSHA $5,400
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)